Keywords
post-Covid cardiac syndrome (PCCS), chronic persistent myoendocarditis (CPME), chronic fibrinous pericarditis (CFP), chronic heart failure (CHF), PLR, NMR, LMR, SII, arterial hypertension combined with dyslipidemia
Abstract
Today, the world is actively identifying new markers that characterize the severity of the condition after suffering from COVID-19. For a more detailed
understanding of what changes the SARS-CoV-2 virus causes in the human body and what is associated with the long-term persistence of symptoms after a new
coronavirus infection, it is necessary to evaluate the relationship between patients with post-Covid cardiac syndromes and clinical blood test parameters.